Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer

NCT00003369 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT00003369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 2
Overall status
Completed
Start date
August 31, 1998
Completion date
July 31, 2004
Enrollment
56 (actual)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer